faropenem sodium and its Impurities
Faropenem Sodium is used in trials studying the treatment of Tuberculosis, Pulmonary Tuberculosis, and Community Acquired Pneumonia.. Reference standards of Faropenem Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
(5R,6S)-6-((R)-1-Hydroxyethyl)-7-oxo-3-((S)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, Sodium Salt
(5R,6S)-6-((R)-1-Hydroxyethyl)-7-oxo-3-((S)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, Sodium Salt
Catalogue No.:PA 06 0041001
CAS :
195716-77-9
Molecular Formula : C12H14NNaO5S
Molecular Weight : 307.30
(5R,6S)-6-Acetyl-7-oxo-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid
(5R,6S)-6-Acetyl-7-oxo-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid
Catalogue No.:PA 06 0041002
CAS :
1376616-67-9
Molecular Formula : C12H13NO5S
Molecular Weight : 283.3
(S,Z)-2-((1S,2R)-1-Carboxy-2-hydroxypropyl)-5-(4-hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylic Acid
(S,Z)-2-((1S,2R)-1-Carboxy-2-hydroxypropyl)-5-(4-hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylic Acid
Catalogue No.:PA 06 0041003
CAS :
754152-74-4
Molecular Formula : C12H17NO6S
Molecular Weight : 303.33
(R,Z)-2-((1R,2S)-1-Carboxy-2-hydroxypropyl)-5-(4-hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylic Acid
(R,Z)-2-((1R,2S)-1-Carboxy-2-hydroxypropyl)-5-(4-hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylic Acid
Catalogue No.:PA 06 0041004
CAS :
191533-80-9
Molecular Formula : C12H17NO6S
Molecular Weight : 303.33
(5R,6S)-6-((R)-1-(((R)-3-Hydroxybutanoyl)oxy)ethyl)-7-oxo-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid
(5R,6S)-6-((R)-1-(((R)-3-Hydroxybutanoyl)oxy)ethyl)-7-oxo-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid
Catalogue No.:PA 06 0041007
CAS :
NA
Molecular Formula : C16H21NO7S
Molecular Weight : 371.4
